Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» Media
Media
13/07/2015
Tasker, S.J. (2015, July 13). Opal Biosciences takes on the superbug.
The Australian Business Review.
Retrieved from
www.theaustralian.com.au
20/07/2015
Opal Biosciences CEO Interview, Wholesale Investor
Latest News
BioDiem Update and EOFY Information
July 4, 2024
24-07-04 BioDiem Update and EOFY information
Read More
Results of GM
April 19, 2024
View Results of AGM
Read More